Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.03
-0.20 (-1.96%)
At close: Oct 30, 2026, 4:00 PM EDT
10.23
+0.20 (1.99%)
After-hours: Oct 30, 2026, 7:55 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $843.73 million as of October 30, 2026. It is the 10,856th most valuable company in the world and the 2,356th biggest in the United States. Its market cap has increased by 47.43% in one year.
Market Cap
843.73M
Enterprise Value
629.23M
1-Year Change
47.43%
Global Rank
Country Rank
#2,356 United States
Category
ChartMarket Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $843.73M, an increase of 190.14%. That is a compound annual growth rate of 10.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 843.70M | 46.70% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 931.84M |
| Monte Rosa Therapeutics | 927.36M |
| Alto Neuroscience | 921.01M |
| Jade Biosciences | 905.63M |
| Obsidian Therapeutics | 896.94M |
| Alumis | 891.81M |
| Inventiva | 882.39M |
| Ginkgo Bioworks Holdings | 857.92M |